An experimental and controversial stem cell transplant, which aims to treat traumatic spinal cord injury, has shown promising new results in a phase I clinical trial.

Not only was the single-dose spinal injection safe and well-tolerated by all 10 patients with paralysis, it also resulted in some improved movement and sensation for 7 volunteers.

While that's seriously hopeful, the type and degree of injury seems to matter. Researchers at the Mayo Clinic in the US admit that in all likelihood, only about five percent of patients with a complete injury to their thoracic spine would regain any feeling or movement with this therapy, based on their results.

Nevertheless, neurosurgeon Mohamad Bydon says: "In spinal cord injury, even a mild improvement can make a significant difference in that patient's quality of life."